The Effect and Safety of Tocilizumab Treatment on IRPF
Conditions:   Idiopathic Retroperitoneal Fibrosis;   Tocilizumab Treatment Interventions:   Drug: Tocilizumab treatment;   Drug: Prednisone Monotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials

High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
Conditions:   COVID-19 Virus Infection;   Cytokine Storm;   Corticosteroid;   Tocilizumab Interventions:   Drug: Methylprednisolone;   Drug: Tocilizumab Sponsor:   Marmara University Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials

The Effect and Safety of Tocilizumab Treatment on IRPF
Conditions:   Idiopathic Retroperitoneal Fibrosis;   Tocilizumab Treatment Interventions:   Drug: Tocilizumab treatment;   Drug: Prednisone Monotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials

High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
Conditions:   COVID-19 Virus Infection;   Cytokine Storm;   Corticosteroid;   Tocilizumab Interventions:   Drug: Methylprednisolone;   Drug: Tocilizumab Sponsor:   Marmara University Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials

The Effect and Safety of Tocilizumab Treatment on IRPF
Conditions:   Idiopathic Retroperitoneal Fibrosis;   Tocilizumab Treatment Interventions:   Drug: Tocilizumab treatment;   Drug: Prednisone Monotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials